Participation in NCI-MATCH is open to patients with various types of cancer, particularly those with advanced or refractory cancers that have not responded to standard treatments. Eligibility largely depends on the genetic profile of the patient's tumor. The trial is open to both adult and pediatric patients who meet specific criteria.
